Travere Therapeutics, Inc. ($TVTX)
Filing Information
| Accession Number | 0001283303-26-000010 |
|---|---|
| Form Type | 4 |
| Filing Date | Sep 18, 2026 |
| Document | View SEC Filing |
Transactions
6
Total Shares
112,500
Total Value
$2,917,445.09
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Legal Officer and GC | Common Stock | โ | Sep 15, 2026 | Exercise/Conversion | 37,500 | $15.46 | $579,750.00 | 142,889 | Direct | โ | View Details | |
Chief Legal Officer and GC | Common Stock | โ | Sep 15, 2026 | Sale | 21,926 | $62.03 | $1,359,971.11 | 120,963 | Direct | โ | View Details | |
Chief Legal Officer and GC | Common Stock | โ | Sep 15, 2026 | Sale | 13,874 | $62.63 | $868,964.69 | 107,089 | Direct | โ | View Details | |
Chief Legal Officer and GC | Common Stock | โ | Sep 15, 2026 | Sale | 1,400 | $63.69 | $89,166.28 | 105,689 | Direct | โ | View Details | |
Chief Legal Officer and GC | Common Stock | โ | Sep 15, 2026 | Sale | 300 | $65.31 | $19,593.00 | 105,389 | Direct | โ | View Details | |
Chief Legal Officer and GC | Employee stock option (right to buy) | Derivative | Sep 15, 2026 | Exercise/Conversion | 37,500 | $0.00 | $0.00 | 0 | Direct | โ | View Details |